This report aims to provide a comprehensive presentation of the global market for Animal Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Biopharma. This report contains market size and forecasts of Animal Biopharma in global, including the following market information:
Global Animal Biopharma Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Animal Biopharma market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Vaccine (Bacteria) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Animal Biopharma include Boehringer Ingelheim, Invetx, CZ Vaccines, Scout Bio, Zoetis, Merck, Elanco, Virbac and Ceva, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Animal Biopharma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Animal Biopharma Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Animal Biopharma Market Segment Percentages, by Type, 2022 (%)
Vaccine (Bacteria)
Immune Serum
Antigen & Antibody
Others
Global Animal Biopharma Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Animal Biopharma Market Segment Percentages, by Application, 2022 (%)
Prevention
Treatment
Global Animal Biopharma Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Animal Biopharma Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Animal Biopharma revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Animal Biopharma revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Invetx
CZ Vaccines
Scout Bio
Zoetis
Merck
Elanco
Virbac
Ceva
Vetoquinol
Outline of Major Chapters:
Chapter 1: Introduces the definition of Animal Biopharma, market overview.
Chapter 2: Global Animal Biopharma market size in revenue.
Chapter 3: Detailed analysis of Animal Biopharma company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal Biopharma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Animal Biopharma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Animal Biopharma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Animal Biopharma Overall Market Size
2.1 Global Animal Biopharma Market Size: 2022 VS 2032
2.2 Global Animal Biopharma Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Animal Biopharma Players in Global Market
3.2 Top Global Animal Biopharma Companies Ranked by Revenue
3.3 Global Animal Biopharma Revenue by Companies
3.4 Top 3 and Top 5 Animal Biopharma Companies in Global Market, by Revenue in 2022
3.5 Global Companies Animal Biopharma Product Type
3.6 Tier 1, Tier 2 and Tier 3 Animal Biopharma Players in Global Market
3.6.1 List of Global Tier 1 Animal Biopharma Companies
3.6.2 List of Global Tier 2 and Tier 3 Animal Biopharma Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Animal Biopharma Market Size Markets, 2022 & 2032
4.1.2 Vaccine (Bacteria)
4.1.3 Immune Serum
4.1.4 Antigen & Antibody
4.1.5 Others
4.2 By Type - Global Animal Biopharma Revenue & Forecasts
4.2.1 By Type - Global Animal Biopharma Revenue, 2018-2023
4.2.2 By Type - Global Animal Biopharma Revenue, 2024-2032
4.2.3 By Type - Global Animal Biopharma Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Animal Biopharma Market Size, 2022 & 2032
5.1.2 Prevention
5.1.3 Treatment
5.2 By Application - Global Animal Biopharma Revenue & Forecasts
5.2.1 By Application - Global Animal Biopharma Revenue, 2018-2023
5.2.2 By Application - Global Animal Biopharma Revenue, 2024-2032
5.2.3 By Application - Global Animal Biopharma Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Animal Biopharma Market Size, 2022 & 2032
6.2 By Region - Global Animal Biopharma Revenue & Forecasts
6.2.1 By Region - Global Animal Biopharma Revenue, 2018-2023
6.2.2 By Region - Global Animal Biopharma Revenue, 2024-2032
6.2.3 By Region - Global Animal Biopharma Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Animal Biopharma Revenue, 2018-2032
6.3.2 US Animal Biopharma Market Size, 2018-2032
6.3.3 Canada Animal Biopharma Market Size, 2018-2032
6.3.4 Mexico Animal Biopharma Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Animal Biopharma Revenue, 2018-2032
6.4.2 Germany Animal Biopharma Market Size, 2018-2032
6.4.3 France Animal Biopharma Market Size, 2018-2032
6.4.4 U.K. Animal Biopharma Market Size, 2018-2032
6.4.5 Italy Animal Biopharma Market Size, 2018-2032
6.4.6 Russia Animal Biopharma Market Size, 2018-2032
6.4.7 Nordic Countries Animal Biopharma Market Size, 2018-2032
6.4.8 Benelux Animal Biopharma Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Animal Biopharma Revenue, 2018-2032
6.5.2 China Animal Biopharma Market Size, 2018-2032
6.5.3 Japan Animal Biopharma Market Size, 2018-2032
6.5.4 South Korea Animal Biopharma Market Size, 2018-2032
6.5.5 Southeast Asia Animal Biopharma Market Size, 2018-2032
6.5.6 India Animal Biopharma Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Animal Biopharma Revenue, 2018-2032
6.6.2 Brazil Animal Biopharma Market Size, 2018-2032
6.6.3 Argentina Animal Biopharma Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Animal Biopharma Revenue, 2018-2032
6.7.2 Turkey Animal Biopharma Market Size, 2018-2032
6.7.3 Israel Animal Biopharma Market Size, 2018-2032
6.7.4 Saudi Arabia Animal Biopharma Market Size, 2018-2032
6.7.5 UAE Animal Biopharma Market Size, 2018-2032
7 Animal Biopharma Companies Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Animal Biopharma Major Product Offerings
7.1.4 Boehringer Ingelheim Animal Biopharma Revenue in Global Market (2018-2023)
7.1.5 Boehringer Ingelheim Key News & Latest Developments
7.2 Invetx
7.2.1 Invetx Company Summary
7.2.2 Invetx Business Overview
7.2.3 Invetx Animal Biopharma Major Product Offerings
7.2.4 Invetx Animal Biopharma Revenue in Global Market (2018-2023)
7.2.5 Invetx Key News & Latest Developments
7.3 CZ Vaccines
7.3.1 CZ Vaccines Company Summary
7.3.2 CZ Vaccines Business Overview
7.3.3 CZ Vaccines Animal Biopharma Major Product Offerings
7.3.4 CZ Vaccines Animal Biopharma Revenue in Global Market (2018-2023)
7.3.5 CZ Vaccines Key News & Latest Developments
7.4 Scout Bio
7.4.1 Scout Bio Company Summary
7.4.2 Scout Bio Business Overview
7.4.3 Scout Bio Animal Biopharma Major Product Offerings
7.4.4 Scout Bio Animal Biopharma Revenue in Global Market (2018-2023)
7.4.5 Scout Bio Key News & Latest Developments
7.5 Zoetis
7.5.1 Zoetis Company Summary
7.5.2 Zoetis Business Overview
7.5.3 Zoetis Animal Biopharma Major Product Offerings
7.5.4 Zoetis Animal Biopharma Revenue in Global Market (2018-2023)
7.5.5 Zoetis Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Animal Biopharma Major Product Offerings
7.6.4 Merck Animal Biopharma Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Elanco
7.7.1 Elanco Company Summary
7.7.2 Elanco Business Overview
7.7.3 Elanco Animal Biopharma Major Product Offerings
7.7.4 Elanco Animal Biopharma Revenue in Global Market (2018-2023)
7.7.5 Elanco Key News & Latest Developments
7.8 Virbac
7.8.1 Virbac Company Summary
7.8.2 Virbac Business Overview
7.8.3 Virbac Animal Biopharma Major Product Offerings
7.8.4 Virbac Animal Biopharma Revenue in Global Market (2018-2023)
7.8.5 Virbac Key News & Latest Developments
7.9 Ceva
7.9.1 Ceva Company Summary
7.9.2 Ceva Business Overview
7.9.3 Ceva Animal Biopharma Major Product Offerings
7.9.4 Ceva Animal Biopharma Revenue in Global Market (2018-2023)
7.9.5 Ceva Key News & Latest Developments
7.10 Vetoquinol
7.10.1 Vetoquinol Company Summary
7.10.2 Vetoquinol Business Overview
7.10.3 Vetoquinol Animal Biopharma Major Product Offerings
7.10.4 Vetoquinol Animal Biopharma Revenue in Global Market (2018-2023)
7.10.5 Vetoquinol Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Animal Biopharma Market Opportunities & Trends in Global Market
Table 2. Animal Biopharma Market Drivers in Global Market
Table 3. Animal Biopharma Market Restraints in Global Market
Table 4. Key Players of Animal Biopharma in Global Market
Table 5. Top Animal Biopharma Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Animal Biopharma Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Animal Biopharma Revenue Share by Companies, 2018-2023
Table 8. Global Companies Animal Biopharma Product Type
Table 9. List of Global Tier 1 Animal Biopharma Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Animal Biopharma Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Animal Biopharma Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Animal Biopharma Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Animal Biopharma Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Animal Biopharma Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Animal Biopharma Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Animal Biopharma Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Animal Biopharma Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Animal Biopharma Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Animal Biopharma Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Animal Biopharma Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Animal Biopharma Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Animal Biopharma Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Animal Biopharma Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Animal Biopharma Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Animal Biopharma Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Animal Biopharma Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Animal Biopharma Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Animal Biopharma Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Animal Biopharma Revenue, (US$, Mn), 2024-2032
Table 30. Boehringer Ingelheim Company Summary
Table 31. Boehringer Ingelheim Animal Biopharma Product Offerings
Table 32. Boehringer Ingelheim Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 33. Boehringer Ingelheim Key News & Latest Developments
Table 34. Invetx Company Summary
Table 35. Invetx Animal Biopharma Product Offerings
Table 36. Invetx Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 37. Invetx Key News & Latest Developments
Table 38. CZ Vaccines Company Summary
Table 39. CZ Vaccines Animal Biopharma Product Offerings
Table 40. CZ Vaccines Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 41. CZ Vaccines Key News & Latest Developments
Table 42. Scout Bio Company Summary
Table 43. Scout Bio Animal Biopharma Product Offerings
Table 44. Scout Bio Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 45. Scout Bio Key News & Latest Developments
Table 46. Zoetis Company Summary
Table 47. Zoetis Animal Biopharma Product Offerings
Table 48. Zoetis Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 49. Zoetis Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Animal Biopharma Product Offerings
Table 52. Merck Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Elanco Company Summary
Table 55. Elanco Animal Biopharma Product Offerings
Table 56. Elanco Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 57. Elanco Key News & Latest Developments
Table 58. Virbac Company Summary
Table 59. Virbac Animal Biopharma Product Offerings
Table 60. Virbac Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 61. Virbac Key News & Latest Developments
Table 62. Ceva Company Summary
Table 63. Ceva Animal Biopharma Product Offerings
Table 64. Ceva Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 65. Ceva Key News & Latest Developments
Table 66. Vetoquinol Company Summary
Table 67. Vetoquinol Animal Biopharma Product Offerings
Table 68. Vetoquinol Animal Biopharma Revenue (US$, Mn) & (2018-2023)
Table 69. Vetoquinol Key News & Latest Developments
List of Figures
Figure 1. Animal Biopharma Segment by Type in 2022
Figure 2. Animal Biopharma Segment by Application in 2022
Figure 3. Global Animal Biopharma Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Animal Biopharma Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Animal Biopharma Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Animal Biopharma Revenue in 2022
Figure 8. By Type - Global Animal Biopharma Revenue Market Share, 2018-2032
Figure 9. By Application - Global Animal Biopharma Revenue Market Share, 2018-2032
Figure 10. By Type - Global Animal Biopharma Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Animal Biopharma Revenue Market Share, 2018-2032
Figure 12. By Application - Global Animal Biopharma Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Animal Biopharma Revenue Market Share, 2018-2032
Figure 14. By Region - Global Animal Biopharma Revenue Market Share, 2018-2032
Figure 15. By Country - North America Animal Biopharma Revenue Market Share, 2018-2032
Figure 16. US Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Animal Biopharma Revenue Market Share, 2018-2032
Figure 20. Germany Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 21. France Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Animal Biopharma Revenue Market Share, 2018-2032
Figure 28. China Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 32. India Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Animal Biopharma Revenue Market Share, 2018-2032
Figure 34. Brazil Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Animal Biopharma Revenue Market Share, 2018-2032
Figure 37. Turkey Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Animal Biopharma Revenue, (US$, Mn), 2018-2032
Figure 41. Boehringer Ingelheim Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Invetx Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. CZ Vaccines Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Scout Bio Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Zoetis Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Elanco Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Virbac Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ceva Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Vetoquinol Animal Biopharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
